The stock was mixed on Monday afternoon as the Dow Jones industrial average turned negative after an early 152-point period to a new high. Airlines have skyrocketed as bookings improve.
X
The Nasdaq rose 0.1%, while the Dow Jones industrial average and the S&P 500 rose 0.2% in the stock market today. Small-cap capitalization followed by the Russell 2000 fell 0.4%. The volume rose higher on both major exchanges by the same time Friday.
Technical stocks raised the Nasdaq to a 43.6% increase in 2020 for its fifth best year ever. The S&P 500 rose 16.3% and the Dow rose 7.2% last year. After a strong start this year, the market is now coming back due to a brief correction. Read the big picture for detailed daily market analysis.
The Covid-19 pandemic is still gripping the U.S. economy as nationwide blockades reach the year mark. But many states are easing restrictions, and there are signs of hope as vaccinations begin to flow and cases in some states begin to flatten.
US stock market overview today |
||||
|---|---|---|---|---|
| Index | Symbol | Price | Profit / loss | % Change |
| Dow jones | (0DJIA) | 32730.38 | -48.26 | -0.15 |
| S&P 500 | (0S & P5) | 3937,24 | -6.10 | -0.15 |
| Nasdaq | (0NDQC) | 13338.79 | +18.93 | +0.14 |
| Russell 2000 | (IWM) | 233,36 | -0.23 | -0.10 |
| IBD 50 | (FFTY) | 47.01 | -0.01 | -0.02 |
Last updated: 12:12 PM ET 3/15/2021 |
||||
Cumulative Covid-19 cases worldwide have reached 120 million numbers, with nearly 2.7 million deaths, according to Worldometer. In the US, cases have exceeded 30 million with more than 547 000 deaths, although the number of new cases in the US has decreased dramatically in recent weeks.
Dow winners and losers
The biggest Dow Jones winner included early Monday appeal (AAPL), Merck (MRK) and Nike (NKE).
Apple rose 2% early on, but increased its profits to 1%. It is now entering its fifth week below the average of ten weeks. Last week, equities tested the 40-week test. On February 18, Apple shares caused the 7% -8% sell-off rule when it fell more than 7% below a buy price of 138.89 from a handle with a handle.
Merck, which is also up 2%, is trying to regain its ten-week line. The drug manufacturer and Gilead Sciences (GILD) has announced that they will jointly develop long-acting treatments for HIV. They will combine Gilead’s lenacapavir and Merck’s islatravir in a two-dose medicine.
Nike rose 2.5% in rapid turnover. Nike shares are approaching a 148.05 flat point in a flat base, according to IBD MarketSmith chart analysis. Shares are down about 3% from the buy point after the 5% advance last week. Nike reported earnings late Thursday.
3M (MMM), up 1%, climbed short of a flat 187.37 from a flat base before comparing its gains. It has advanced almost 7% this year, but a 34 relative strength rating means that 3M owns 64% of all other stocks.
The biggest Dow losers included Chevron (CVX) and Dow Inc. (DOW), down more than 2% each.
Outside The Dow
Oil and gas, steel and banking stocks led the downside among IBD’s 197 industry groups. But clothing retailers, airlines and other travel supplies performed better.
In the airline group, United Airlines (UAL) increased its rapid turnover by 8% to an annual high. Shares are expanding almost 20% from a buy point of 51.41 on a cup basis. The Chicago-based airline said these are increased travel bookings and that the core cash flow will be positive if it continues.
American Airlines (AAL) and Jetblue Airways (JBLU) rose by more than 5% to the level of the market crash. Airlines, hotels and other travel supplies held a recent rally as a plateau for coronavirus.
Virtu Financial (VIRT) broke out early Monday at a 29.86 buyout of a six-week flat basis before declining profits below the entry. The stock rose about 0.5% at lunch. The Stock Exchange’s 90 Composite Rating ranks fifth in the 53-share specialty services group. A value of 98 earnings per share, which is part of the overall composite score, leads the group.
Drug manufacturer dives
Eli Lilly (LLY) fell and plunged more than 8% into massive trading, exceeding the 50-day moving average for the first time since December. The stock tumbled below the bottom of a flat base with a buying point of 218.10. At 12% below left level, it is still technically in a flat base range. But the sharp break of the 50-day line is a sell signal.
The drugmaker on Saturday released more details from a phase two study of the drug against Alzheimer’s disease. But some secondary goals were mixed.
Caesars Entertainment (CZR), Generac (GNRC), NXP Semiconductors (NXPI) and Penn National Gaming (PENN) gathered late on Friday for the news that they will join the S&P 500 index before the opening day on March 22.
Generac, 0.6% lower, is an IBD Leaderboard and IBD 50 stock. Generac jumped back from its ten-week line last week to give it a chance to buy. But it has now been expanded from the next entry. Equities also reached the 20% -25% profit target from a 234.65 buy base point, allowing investors to make some gains.
Follow Nancy Gondo on Twitter @IBD_NGondo
YOU MAY ALSO LIKE THIS:
Will this top FinTech achieve three-digit profit?
Discover today’s best growth stocks to watch with IBD 50
Learn how to determine the market with the ETF market strategy of IBD
See stocks on the list of market leaders with IBD rankings